What does CUSIP 86627T108 represent in this 13F holders report?

CUSIP 86627T108 is the security identifier for SMMT - Summit Therapeutics Inc. - COM used to aggregate holder disclosures.

How many institutions held SMMT - Summit Therapeutics Inc. - COM in Q1 2023?

86 institutional investors reported SMMT - Summit Therapeutics Inc. - COM for Q1 2023. Use the holders table for investor-level position and value details.

Summit Therapeutics Inc. - COM (SMMT)

CUSIP: 86627T108

Q1 2023 13F Holders as of 31 Mar 2023

Security type / class: Equity / COM
Total 13F shares: 21,131,959
Total 13F value: $36,976,249
Share change: +13,005,833
Put/Call ratio: 91%
SEC-reported price per share: $1.75
Number of holders: 86
Value change: +$21,762,761
Number of buys: 66
Number of sells: 18

Security key

86627T108

Report period

Q1 2023

Institutions

Top holders

SMMT full security history Ownership snapshot Full 13F holder table Summit Therapeutics Inc. SEC filings Summit Therapeutics Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of SMMT - Summit Therapeutics Inc. - COM (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

BAKER BROS. ADVISORS LP

Disclosed value leader

BAKER BROS. ADVISORS LP

Comparable rows

0/15

Latest evidence

31 Dec 2022

13F 3/4/5 Highest disclosed value: $8,500,000 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

BAKER BROS. ADVISORS LP has the largest disclosed position value at $8.5M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens BAKER BROS. ADVISORS LP's linked filing trail.

Disclosed position value Top 5

BAKER BROS. ADVISORS LP $8.5M

VANGUARD GROUP INC $6.14M

MARSHALL WACE, LLP $2.65M

BlackRock Finance, Inc. $2.27M

GEODE CAPITAL MANAGEMENT, LLC $2M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
BAKER BROS. ADVISORS LP	13F Company 13F	— class O/S missing	$8,500,000 2,000,000 shares	—	31 Dec 2022
VANGUARD GROUP INC	13F Company 13F	— class O/S missing	$6,135,121 1,443,558 shares	—	31 Dec 2022
MARSHALL WACE, LLP	13F Company 13F	— class O/S missing	$2,647,182 622,866 shares	—	31 Dec 2022
BlackRock Finance, Inc.	13F Company 13F	— class O/S missing	$2,272,306 534,660 shares	—	31 Dec 2022
GEODE CAPITAL MANAGEMENT, LLC	13F Company 13F	— class O/S missing	$2,004,000 471,673 shares	—	31 Dec 2022
Steward Partners Investment Advisory, LLC	13F Company 13F	— class O/S missing	$1,296,250 305,000 shares	—	31 Dec 2022

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

21,131,959

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2023 vs Q1 2023 Across Filers

Q1 2023 holders

Holder diff

Investor	Q1 2023 Shares	Q1 2023 Shares	Share Diff	Share Chg %	Q1 2023 value	Q1 2023 value	Value change	Value Chg %